148 related articles for article (PubMed ID: 29177538)
1. Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [
Koch CJ
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):159-160. PubMed ID: 29177538
[No Abstract] [Full Text] [Related]
2. Repeatability of tumour hypoxia imaging using [
Silvoniemi A; Suilamo S; Laitinen T; Forsback S; Löyttyniemi E; Vaittinen S; Saunavaara V; Solin O; Grönroos TJ; Minn H
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):161-169. PubMed ID: 29075831
[TBL] [Abstract][Full Text] [Related]
3. Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer.
Wright P; Arnesen MR; Lønne PI; Suilamo S; Silvoniemi A; Dale E; Minn H; Malinen E
Acta Oncol; 2021 Nov; 60(11):1386-1391. PubMed ID: 34184605
[TBL] [Abstract][Full Text] [Related]
4. Atypical
Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
[TBL] [Abstract][Full Text] [Related]
5.
Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
[TBL] [Abstract][Full Text] [Related]
6. [(18)F-FDG PET/CT: Image-guided surveillance in advanced head and neck cancer as an alternative to neck dissection].
Derlin T
Radiologe; 2016 Sep; 56(9):773-4. PubMed ID: 27502005
[No Abstract] [Full Text] [Related]
7. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
[TBL] [Abstract][Full Text] [Related]
8. Should (18)F FDG PET/CT Really Be Indicated in Routine Clinical Practice for Detecting Contralateral Neck Node Metastasis in Head and Neck Squamous Cell Carcinoma?
Mahajan A; Paul PP; Arya S
Radiology; 2016 Aug; 280(2):651-2. PubMed ID: 27429149
[No Abstract] [Full Text] [Related]
9. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
[TBL] [Abstract][Full Text] [Related]
10. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
[TBL] [Abstract][Full Text] [Related]
12. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer.
Kobayashi K; Kurihara H; Watanabe Y; Murakami N; Inaba K; Nakamura S; Wakita A; Okamoto H; Umezawa R; Takahashi K; Igaki H; Ito Y; Yoshimoto S; Shigematsu N; Itami J
Appl Radiat Isot; 2016 Sep; 115():138-146. PubMed ID: 27372808
[TBL] [Abstract][Full Text] [Related]
13. [PET-CT in head and neck cancer].
Send T; Kreppel B; Gaertner FC; Bundschuh RA; Strunk H; Bootz F; Essler M
HNO; 2017 Jun; 65(6):504-513. PubMed ID: 28451717
[TBL] [Abstract][Full Text] [Related]
14. CT, MRI, and
Kim HY; Hwang JY; Kim HJ; Kim YK; Cha J; Park GM; Kim ST
Acta Radiol; 2017 Oct; 58(10):1222-1230. PubMed ID: 28068826
[TBL] [Abstract][Full Text] [Related]
15. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
Kitajima K; Suenaga Y; Sugimura K
Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
[TBL] [Abstract][Full Text] [Related]
16. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography/computed tomography for target delineation in head and neck cancers.
Ahn PH; Garg MK
Semin Nucl Med; 2008 Mar; 38(2):141-8. PubMed ID: 18243850
[TBL] [Abstract][Full Text] [Related]
18. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
19. Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
Choi W; Lee SW; Park SH; Ryu JS; Oh SJ; Im KC; Choi EK; Kim JH; Jung SH; Kim S; Ahn SD
Radiother Oncol; 2010 Nov; 97(2):176-82. PubMed ID: 20855118
[TBL] [Abstract][Full Text] [Related]
20. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
Schinagl DA; Troost EG; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513
[No Abstract] [Full Text] [Related]
[Next] [New Search]